CAS 57164-17-7

Formel: C18H21N3O

InChl: InChI=1S/C18H21N3O/c1-20(19-22)13-6-14-21-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)21/h2-5,7-10H,6,11-14H2,1H3

InChI Key: OZJGLIPPPYOOCK-UHFFFAOYSA-N

SMILES: CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)N=O

N-Nitroso Desipramine Solution (1 mL ) (N-[3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N-methylnitrous amide)

CAS: 57164-17-7

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Formel: C₁₈H₂₁N₃O

Farbe und Form: Light Yellow Liquid

Molekulargewicht: 295.16846

Ref: 45-1A09770

N-Nitroso Desipramine

CAS: 57164-17-7

Formel: C₁₈H₂₁N₃O

Molekulargewicht: 295.39

Ref: 4Z-D-029

N-Nitrosodesipramine

CAS: 57164-17-7

Formel: C₁₈H₂₁N₃O

Farbe und Form: Neat

Molekulargewicht: 295.38

Ref: TR-N137390

N-Nitrosodesipramine

CAS: 57164-17-7

N-Nitrosodesipramine is an analog of the antidepressant drug desipramine that has been shown to have anticancer properties. It inhibits the activity of kinases, which are proteins that play a key role in cancer cell growth and division. N-Nitrosodesipramine has been found to induce apoptosis, or programmed cell death, in human and Chinese hamster cancer cells. This compound is also a potent inhibitor of tolvaptan, a drug used to treat hyponatremia (low sodium levels) in patients with heart failure or liver disease. N-Nitrosodesipramine is excreted in urine and may be useful as a biomarker for exposure to nitrosamines, which are known carcinogens.

Formel: C₁₈H₂₁N₃O

Reinheit: Min. 95%

Farbe und Form: Clear Liquid

Molekulargewicht: 295.4 g/mol

Ref: 3D-HCA16417

N-Nitroso Desipramine

CAS: 57164-17-7

Formel: C₁₈H₂₁N₃O

Molekulargewicht: 295.39

Ref: ST-EA-CP-D34004